Daily Stock Analysis, SRDX, SurModics Inc, priceseries

SurModics Inc. Daily Stock Analysis
Stock Information
Open
43.46
Close
43.19
High
43.57
Low
42.68
Previous Close
43.40
Daily Price Gain
-0.21
YTD High
50.86
YTD High Date
Jan 4, 2022
YTD Low
36.24
YTD Low Date
Feb 3, 2022
YTD Price Change
-6.53
YTD Gain
-13.13%
52 Week High
62.27
52 Week High Date
Sep 2, 2021
52 Week Low
36.24
52 Week Low Date
Feb 3, 2022
52 Week Price Change
-11.43
52 Week Gain
-20.93%
Recent priceSeries Trade Signals

These are sample algorithmic trades based on actual market data.

Trade Type
Entry Date
Entry Price
Exit Date
Exit Price
Trade Hold Time
Gain
Trade Record
LONG
Jun 22. 2017
25.20
Jul 10. 2017
27.48
11 Trading Days
9.06%
Link
LONG
Aug 31. 2017
26.00
Oct 9. 2017
31.40
26 Trading Days
20.76%
Link
LONG
Feb 27. 2018
29.85
Apr 2. 2018
36.86
23 Trading Days
23.49%
Link
LONG
May 2. 2018
38.95
Jun 26. 2018
55.08
38 Trading Days
41.41%
Link
LONG
Aug 6. 2018
65.35
Sep 17. 2018
78.06
29 Trading Days
19.45%
Link
LONG
Feb 11. 2019
52.96
Mar 4. 2019
56.91
14 Trading Days
7.46%
Link
LONG
Mar 24. 2020
28.97
Apr 3. 2020
31.80
8 Trading Days
9.78%
Link
LONG
Jun 2. 2020
38.01
Jun 11. 2020
40.77
7 Trading Days
7.26%
Link
LONG
Dec 28. 2020
39.99
Jan 8. 2021
43.45
8 Trading Days
8.66%
Link
LONG
Feb 8. 2021
45.79
Feb 18. 2021
49.28
7 Trading Days
7.61%
Link
LONG
Dec 17. 2021
45.24
Jan 5. 2022
48.09
12 Trading Days
6.31%
Link
Company Information
Stock Symbol
SRDX
Exchange
NasdaqGS
Company URL
http://www.surmodics.com
Company Phone
9525007000
CEO
Gary R. Maharaj
Headquarters
Minnesota
Business Address
9924 W 74TH ST, EDEN PRAIRIE, MN 55344
Sector
Equity
Industry Category
Drugs
Industry Group
Diagnostic Substances
CIK
0000924717
About

SurModics, Inc. provides surface modification and in vitro diagnostic technologies to the healthcare industry. The company offers surface modification coating technologies and components for in vitro diagnostic test kits and microarrays. It operates through two segments: Medical Device and In Vitro Diagnostics. The Medical Device segment engages in contract research and development, as well as manufacturing of balloons catheters used for a variety of interventional cardiology applications. The In Vitro Diagnostics segment manufactures or sells components for in vitro diagnostic immunoassay and molecular tests. SurModics was founded in June 1979 and is headquartered in Eden Prairie, MN.

Description

Surmodics, Inc., together with its subsidiaries, provides surface modification and in vitro diagnostic technologies to the healthcare industry worldwide. It operates through two segments, Medical Device and In Vitro Diagnostics. The Medical Device segment offers surface modification coating technologies to enhance access, deliverability, and predictable deployment of medical devices, as well as drug delivery coating technologies to provide site-specific drug delivery from the surface of a medical device for the coronary, peripheral, neuro-vascular, urology, and other markets. This segment also engages in the contract research, development, and manufacture of percutaneous transluminal angioplasty balloon catheters for use in various interventional cardiology, peripheral, and other applications. The Vitro Diagnostics segment provides component products and technologies that include protein stabilization reagents, substrates, antigens, and surface coatings for diagnostic immunoassay and molecular tests, as well as to the diagnostic, biomedical research, and life science markets. SurModics, Inc. was founded in 1979 and is headquartered in Eden Prairie, Minnesota.